Related Experiment Video

Updated: Oct 17, 2026

Generation of Myospheres From hESCs by Epigenetic Reprogramming
09:32

Generation of Myospheres From hESCs by Epigenetic Reprogramming

Published on: June 21, 2014

pRb controls proliferation, differentiation, and death of skeletal muscle cells and other lineages during

E Zacksenhaus1, Z Jiang, D Chung

  • 1Department of Molecular and Medical Genetics, University of Toronto, Ontario, Canada.

Genes & Development
|December 1, 1996
PubMed

Insights

The Retinoblastoma (RB) gene is crucial for skeletal muscle development. Insufficient RB protein (pRb) causes myoblast apoptosis and prevents proper myotube formation and cell cycle exit.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Genetics

Background:

  • The Retinoblastoma (RB) gene (RB1) plays a vital role in cell cycle regulation and differentiation.
  • RB-deficient mice (RB-/-) exhibit embryonic lethality with widespread cell death in tissues expressing RB1.
  • Understanding RB's function in specific tissues like skeletal muscle is crucial for developmental insights.

Purpose of the Study:

  • To investigate the role of insufficient Retinoblastoma protein (pRb) levels in skeletal muscle development in vivo.
  • To elucidate the specific defects in myogenesis caused by reduced pRb function.
  • To determine if pRb influences myoblast survival, differentiation, and cell cycle exit during muscle formation.

Main Methods:

  • Generation of transgenic mice (RBlox) expressing low levels of pRb via an RB1 minigene.
  • Analysis of RBlox/RB-/- double mutant fetuses, which exhibit skeletal muscle defects.
  • Assessment of myoblast apoptosis, myotube morphology, nuclear content, and expression of muscle-specific genes (MCK, MRF4).

Main Results:

  • RBlox/RB-/- mutant fetuses die at birth with severe skeletal muscle defects.
  • Observed defects include increased myoblast apoptosis before fusion, shorter myotubes with fewer myofibrils, and reduced muscle fiber formation.
  • Accumulation of polyploid nuclei within myotubes indicates a failure in permanent cell cycle withdrawal, alongside reduced expression of late muscle genes.

Conclusions:

  • Insufficient pRb function leads to the failure of myogenesis in vivo.
  • pRb is essential for both myoblast survival (preventing apoptosis) and the proper terminal differentiation of skeletal muscle cells.
  • pRb acts as a critical regulator controlling cell proliferation, differentiation, and death during skeletal muscle development.

More Related Videos

Preparation of Primary Myogenic Precursor Cell/Myoblast Cultures from Basal Vertebrate Lineages07:51

Preparation of Primary Myogenic Precursor Cell/Myoblast Cultures from Basal Vertebrate Lineages

Published on: April 30, 2014

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry14:47

Identification of MyoD Interactome Using Tandem Affinity Purification Coupled to Mass Spectrometry

Published on: May 17, 2016

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Formation of Muscle Fibers from Myoblasts01:13

Formation of Muscle Fibers from Myoblasts

De novo myogenesis, or the formation of muscle fibers, begins during the early embryonic stages. The skeletal muscle is formed from somites– blocks of embryonic cell layers. The somites are further divided into dermatomes, myotomes, sclerotomes, and syndetomes. Among these, the myotomes give rise to muscle fibers.
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012 for this...